Was Q2 The Turning Point For Pfizer Stock?

With Pfizer’s sales rising in Q2, despite falling sales of Covid-19 products, we think that it may well be the turning point for Pfizer stock (NYSE:PFE). It has seen a decline of 15% from levels of $35 in early January 2021 to around $30 now, vs. an increase of about 65% fo